References
- Al‐Saadi S A, Gross P, Wildy P. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus. J Gen Virol 1988; 69: 433–438
- Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first‐episode infection. Ann Intern Med 1994; 121: 847–854
- Block T, Barney S, Masonis J, Maggioncalda J, Valyi‐Nagy T, Fraser N W. Long term herpes simplex virus type 1 infection of nerve growth factor‐treated PC12 cells. J Gen Virol 1994; 75: 2481–2487
- Bourne N, Stanberry L R, Connelly B L, Kurawadwala J, Straus S E, Krause P R. Quantity of latency‐associated transcript produced by herpes simplex virus is not predictive of the frequency of experimental recurrent genital herpes. J Infect Dis 1994; 169: 1084–1087
- Colberg‐Poley A M, Isom H C, Rapp F. Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus. Proc Nat Acad Sci USA 1979; 76: 5948–5951
- Colberg‐Poley A M, Isom H C, Rapp F. Involvement of an early human cytomegalovirus function in reactivation of quiescent herpes simplex virus type 2. J Virol 1981; 37: 1051–1059
- Croen K D, Ostrove J M, Dragovic L, Straus E. Characterization of herpes simplex virus type 2 latency‐associated transcription in human sacral ganglia and in cell culture. J Infect Dis 1991; 163: 23–28
- Danaher R J, Jacob R J, Miller C S. Establishment of a quiescent herpes simplex virus type 1 infection in neurally differentiated PC12 cells. J NeuroVirol 1999a; 5: 258–267
- Danaher R J, Jacob R J, Chorak M D, Freeman C S, Miller C S. Heat stress induces reactivation of herpes simplex virus type 1 from quiescently infected neurally differentiated PC12 cells. J NeuroVirol 1999b; 5: 374–383
- Dolan A, Jamieson F E, Cunningham C, Barnett B C, McGeoch D J. The genome sequence of herpes simplex virus type 2. J Virol 1998; 72: 2010–2021
- Hammer S M, Richter B S, Hirsch M S. Activation and supp ression of herpes simplex virus in a human T lymphoid cell line. J Immunol 1981; 127: 144–148
- Harris R A, Everett R D, Zhu X, Silverstein S, Preston C M. The HSV immediate early protein VMV 110 reactivates latent HSV type 2 in an in vitro latency system. J Virol 1989; 63: 3513–3515
- Harris R A, Preston C M. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in 1814. J Gen Virol 1991; 72: 907–913
- Hill T J, Field H J, Roome A P C. Intraxonal location of herpes simplex virus particles. J Gen Virol 1972; 15: 253–257
- Kieff E D, Bachenheimer S L, Roizman B. Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2. J Virol 1971; 8: 125–132
- Kieff E, Hoyer B, Bachenheimer S, Roizman B. Genetic relatedness of type 1 and type 2 herpes simplex viruses. J Virol 1972; 9: 738–745
- Kondo Y, Yura Y, Iga H, Yanagawa T, Yoshida H, Furumoto N, Sato M. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line. Cancer Res 1990; 50: 7852–7857
- Krause P R, Stanberry L R, Bourne N, Connelly B, Kurawadwala J F, Patel A, Straus S E. Expression of the herpes simplex virus type 2 latency‐associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med 1995; 181: 297–306
- Kurata T, Kurata K, Aoyama K. Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment. Jpn J Exp Med 1978; 48: 427–435
- MacLean A, Robertson L, McKay E, Brown S M. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency. J Gen Virol 1991; 72: 2305–2310
- Martin J R, Suzuki S. Targets of infection in a herpes simplex‐reactivation model. Acta Neuropathol (Bed) 1989; 77: 402–411
- Miller C S, Smith K O. Enhanced replication of herpes simplex virus type 1 in human cells. J Dent Res 1991; 70: 111–117
- Mitchell W J, Deshmane S L, Dolan A, McGeoch D J, Fraser N W. Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J Virol 1990; 64: 5342–5348
- O'Neill F. Prolongation of herpes simplex virus latency in cultured human cells by temperature elevation. J Virol 1977; 24: 41–46
- O'Neill F J, Goldberg R J, Rapp F. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside. J Gen Virol 1972; 14: 189–197
- Russell J, Stow N D, Stow E C, Preston C M. Herpes simplex virus genes involved in latency, in vitro. J Gen Virol 1987; 68: 3009–3018
- Russell J, Preston C M. An in vitro latency system for herpes simplex virus type 2. J Gen Virol 1986; 67: 397–403
- Scheck A C, Wigdahl B, Rapp F. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency. Intervirology 1989; 30: 121–136
- Stanberry L R, Kern E R, Richards J T, Abbott T M, Overall J C, Jr. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis 1982; 146: 397–404
- Stephanopoulos D E, Kapp es J C, Bernstein D I. Enhanced in vitro reactivation of herpes simplex virus type 2 from latently infected guinea‐pig neural tissues by 5‐azacytidine. J Gen Virol 1988; 69: 1079–1083
- Stevens J G, Cook M L. Latent herpes simplex virus in spinal ganglia of mice. Science 1971; 173: 843–845
- Su Y ‐H, Meegalla R L, Chowhan R, Cubitt C, Oakes J E, Lausch R N, Fraser N W, Block T M. Human corneal cells and other fibroblasts can stimulate the app earance of herpes simplex virus from quiescently infected PC12 cells. J Virol 1999; 73: 4171–4180
- Wang K, Pesnicak L, Straus S E. Mutations in the 5′ end of the herpes simplex virus type 2 latency‐associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes. J Virol 1997; 71: 7903–7910
- Whitley R J. Herpes simplex viruses. Fields Virology3rd edition., B N Fields, D M Knipe, P M Howley. Lipp incott‐Raven Publishers, Philadelphia 1996; 2297–2342
- Wigdahl B L, Isom H C, Rapp F. Repression and activation of the genome of herpes simplex viruses in human cells. Proc Natl Acad Sci 1981; 78: 6522–6526
- Wigdahl B L, Scheck A C, De Clercq E, Rapp F. High efficiency latency and activation of herpes simplex virus in human cells. Science 1982; 217: 1145–1146
- Wilcox C L, Johnson E M, Jr. Characterization of nerve factor‐dependent herpes simplex virus latency in neurons in vitro. J Virol 1988; 62: 393–399
- Wilcox C L, Smith R L, Freed C R, Johnson E M, Jr. Nerve growth factor‐dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neuroscience 1990; 10: 1268–1275
- Yoshikawa T, Stanberry L R, Bourne N, Krause P R. Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency‐associated transcript expression but do not influence recurrence phenotype or establishment of latency. J Virol 1996; 70: 1535–1541
- Yura Y, Terashima K, Iga H, Yanagawa T, Yoshida H, Hayashi Y, Sato M. A latent infection of herpes simplex virus type 2 in a neuroblastoma cell line IMR‐32. Arch Virol 1986; 90: 249–260